Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. APUS
APUS logo

APUS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Apimeds Pharmaceuticals US Inc (APUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.360
1 Day change
0.74%
52 Week Range
4.030
Analysis Updated At
2026/03/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

APUS is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits weak financial performance, no significant trading trends, and lacks positive catalysts. Additionally, technical indicators suggest a bearish trend, and there are no strong proprietary trading signals to support a buy decision.

Technical Analysis

The MACD histogram is positive but contracting, indicating weakening momentum. RSI is neutral at 42.596, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 1.344, with key support at 1.214 and resistance at 1.474. Overall, the technical indicators suggest a bearish trend.

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders.

Neutral/Negative Catalysts

  • is also down by 0.56%. Financial performance is weak, with no revenue and negative net income.

Financial Performance

In Q3 2025, the company reported no revenue growth (0.00% YoY) and a net income of -$1,781,255, which, while improving by 435.68% YoY, remains negative. EPS improved to -0.14 (up 366.67% YoY) but is still in the negative territory. Gross margin remains at 0, showing no profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available for APUS.

Wall Street analysts forecast APUS stock price to rise
Analyst Rating
0
Wall Street analysts forecast APUS stock price to rise
Buy
Hold
Sell
0
Current: 1.350
sliders
Low
0
Averages
0
High
0
0
Current: 1.350
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch